Lista de obras - Miquel Bioque - Dominio Público Uruguay

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

artículo científico publicado en 2015

A functional variant provided further evidence for the association of ARVCF with schizophrenia

artículo científico publicado en 2010

Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis

artículo científico publicado en 2015

An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).

artículo científico publicado en 2017

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

artículo científico publicado en 2012

Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period

artículo científico publicado en 2020

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.

artículo científico publicado en 2015

Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

artículo científico publicado en 2016

Blood cell count in antipsychotic-naive patients with non-affective psychosis.

artículo científico publicado en 2017

CLOZAPINE AND PALIPERIDONE PALMITATE ANTIPSYCHOTIC COMBINATION IN TREATMENT-RESISTANT SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS: A RETROSPECTIVE 6-MONTH MIRROR-IMAGE STUDY

artículo científico publicado en 2020

Cannabis use, COMT, BDNF and age at first-episode psychosis

artículo científico publicado en 2017

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis.

artículo científico publicado en 2017

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

artículo científico publicado en 2016

Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?

scientific article published in 2023

Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.

artículo científico publicado en 2016

Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.

artículo científico publicado en 2017

Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development Study

artículo científico publicado en 2023

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

artículo científico publicado en 2017

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

scientific article published on 07 May 2019

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis

artículo científico publicado en 2018

Inflammation in schizophrenia: A question of balance.

artículo científico publicado en 2015

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)

scientific article published on 04 December 2019

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

artículo científico publicado en 2017

Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?

artículo científico publicado en 2016

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

artículo científico publicado en 2018

Metabolic syndrome or glucose challenge in first episode of psychosis?

artículo científico publicado en 2016

Modelling gene-environment interaction in first episodes of psychosis

artículo científico publicado en 2017

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

artículo científico publicado en 2019

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

artículo científico publicado en 2016

Peripheral endocannabinoid system dysregulation in first-episode psychosis

artículo científico publicado en 2013

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset

artículo científico publicado en 2017

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

artículo científico publicado en 2016

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

artículo científico publicado en 2015

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia

artículo científico publicado en 2013

Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study

artículo científico publicado en 2014

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review

artículo científico publicado en 2015

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.

artículo científico publicado en 2017

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients.

artículo científico publicado en 2010

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

artículo científico publicado en 2017

The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia

artículo científico publicado en 2018

The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds

artículo científico publicado en 2021

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study.

artículo científico publicado en 2016

The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

scientific article published on 24 April 2020

The search for new biomarkers for cognition in schizophrenia

artículo científico publicado en 2015

Three-month paliperidone palmitate - a new treatment option for schizophrenia

artículo científico publicado en 2016

Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.

artículo científico publicado en 2010

¿Qué hemos aprendido de la investigación en primeros episodios psicóticos?

scientific article published on 01 April 2014

Lista de obras de Miquel Bioque

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

A functional variant provided further evidence for the association of ARVCF with schizophrenia

Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis

An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.

Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

Blood cell count in antipsychotic-naive patients with non-affective psychosis.

CLOZAPINE AND PALIPERIDONE PALMITATE ANTIPSYCHOTIC COMBINATION IN TREATMENT-RESISTANT SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS: A RETROSPECTIVE 6-MONTH MIRROR-IMAGE STUDY

Cannabis use, COMT, BDNF and age at first-episode psychosis

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis.

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?

Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.

Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.

Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development Study

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis

Inflammation in schizophrenia: A question of balance.

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

Metabolic syndrome or glucose challenge in first episode of psychosis?

Modelling gene-environment interaction in first episodes of psychosis

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

Peripheral endocannabinoid system dysregulation in first-episode psychosis

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia

Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients.

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia

The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study.

The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

The search for new biomarkers for cognition in schizophrenia

Three-month paliperidone palmitate - a new treatment option for schizophrenia

Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.

¿Qué hemos aprendido de la investigación en primeros episodios psicóticos?